PharmaEngine (ROCO:4162) Tax Provision: NT$-129.6 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4162 PharmaEngine Inc ROCO:4162
82 GF Score
Price NT$63.70
GF Value NT$108.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PharmaEngine Tax Provision?

PharmaEngine ROCO:4162 -1.55% 82 Tax Provision is NT$-129.6 Mil as of Mar. 2026. GuruFocus rates ROCO:4162 with a GF Score™ of 82/100 and a GF Value™ of NT$108.31 (Possible Value Trap). The stock has 4 warning signs investors should review.

PharmaEngine's tax provision for the three months ended in Mar. 2026 was NT$-33.5 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-129.6 Mil.

PharmaEngine Tax Provision Historical Data

* Premium members only.

The historical data trend for PharmaEngine's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEngine Tax Provision Chart

PharmaEngine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -119.36 -73.68 -63.32 -411.97 -121.65

PharmaEngine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.58 -25.77 -34.12 -36.19 -33.51
ROCO:4162
82GF Score
PharmaEngine Inc ROCO:4162
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEngine Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-129.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of NT$-129.6 Mil mean?
PharmaEngine (ROCO:4162) has a Tax Provision of NT$-129.6 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on PharmaEngine and its competitors.
Is PharmaEngine's Tax Provision too high?
PharmaEngine's current Tax Provision is NT$-129.6 Mil. Overall, PharmaEngine has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PharmaEngine's Tax Provision compare to VRTX and REGN?
PharmaEngine's Tax Provision of NT$-129.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on PharmaEngine and its competitors. PharmaEngine's current Tax Provision is NT$-129.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEngine stock overvalued right now?
Based on GuruFocus' analysis, PharmaEngine (ROCO:4162) is currently considered Possible Value Trap. The stock's GF Value™ is NT$108.31, compared to a current price of NT$63.70 — trading 41.2% below its estimated fair value. The current Tax Provision is NT$-129.6 Mil. PharmaEngine's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For PharmaEngine (ROCO:4162), the current Tax Provision is NT$-129.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEngine (ROCO:4162) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEngine stock appears to be undervalued. The current stock price of NT$63.70 is trading 41.2% below its estimated GF Value™ of NT$108.31. GuruFocus considers PharmaEngine to be Possible Value Trap.

Key valuation signals for ROCO:4162:

  • Tax Provision: NT$-129.6 Mil
  • GF Value™: NT$108.31 vs. price of NT$63.70 (41.2% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4162 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEngine Business Description

Address No. 10, Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its key products and pipeline projects include ONIVYDE, a treatment for metastatic pancreatic cancer approved in multiple markets, as well as oncology candidates such as PEP07 and PEP08. It generates revenue from the sales of goods.
82GF Score

Get the complete analysis for ROCO:4162

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.70
Price
NT$108.31
GF Value